Initially, we investigated whether Tyr31 phosphorylated paxillin [PXN (p-Y31)] can be a marker of HCC progression by examining the status of PXN(p-Y31) in HCC tissues obtained from surgery in TUZ CHI Hospital. Here, PXN is linked to hepatocellular carcinoma.